QR-Code

Multiparticulate Systems of Meloxicam for Colonic Administration in Cancer or Autoimmune Diseases

The aim of this research is the development of new colonic release systems of meloxicam (MLX) a non-steroidal anti-inflammatory drug (NSAIDs) with pH and time-dependent vehicles for cancer or autoimmune diseases. The colon has a higher pH than the rest of the gastrointestinal tract (GIT) and this ca...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Eva Navarro-Ruíz, Covadonga Álvarez-Álvarez, M Ángeles Peña, Carlos Torrado-Salmerón, Zaid Dahma, Paloma Marina de la Torre-Iglesias
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI AG 2022-07-01
Schriftenreihe:Pharmaceutics
Schlagworte:
multiparticulate system
autoimmune disease
cancer
colonic administration
meloxicam
Online-Zugang:https://www.mdpi.com/1999-4923/14/7/1504
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge